PortfoliosLab logoPortfoliosLab logo
TMFX vs. BOUT
Performance
Return for Risk
Dividends
Drawdowns
Volatility

Performance

TMFX vs. BOUT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Motley Fool Next Index ETF (TMFX) and Innovator IBD Breakout Opportunities ETF (BOUT). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

TMFX vs. BOUT - Yearly Performance Comparison


2026 (YTD)2025202420232022
TMFX
Motley Fool Next Index ETF
-7.21%10.41%16.04%17.95%-28.16%
BOUT
Innovator IBD Breakout Opportunities ETF
9.59%-6.77%18.82%13.27%-22.60%

Returns By Period

In the year-to-date period, TMFX achieves a -7.21% return, which is significantly lower than BOUT's 9.59% return.


TMFX

1D
0.12%
1M
-7.53%
YTD
-7.21%
6M
-7.49%
1Y
8.98%
3Y*
9.68%
5Y*
10Y*

BOUT

1D
1.26%
1M
-3.95%
YTD
9.59%
6M
2.35%
1Y
10.03%
3Y*
9.30%
5Y*
4.29%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


TMFX vs. BOUT - Expense Ratio Comparison

TMFX has a 0.50% expense ratio, which is lower than BOUT's 0.80% expense ratio.


Return for Risk

TMFX vs. BOUT — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

TMFX
TMFX Risk / Return Rank: 2424
Overall Rank
TMFX Sharpe Ratio Rank: 2222
Sharpe Ratio Rank
TMFX Sortino Ratio Rank: 2424
Sortino Ratio Rank
TMFX Omega Ratio Rank: 2323
Omega Ratio Rank
TMFX Calmar Ratio Rank: 2727
Calmar Ratio Rank
TMFX Martin Ratio Rank: 2727
Martin Ratio Rank

BOUT
BOUT Risk / Return Rank: 2525
Overall Rank
BOUT Sharpe Ratio Rank: 2525
Sharpe Ratio Rank
BOUT Sortino Ratio Rank: 2424
Sortino Ratio Rank
BOUT Omega Ratio Rank: 2424
Omega Ratio Rank
BOUT Calmar Ratio Rank: 2929
Calmar Ratio Rank
BOUT Martin Ratio Rank: 2626
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

TMFX vs. BOUT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Motley Fool Next Index ETF (TMFX) and Innovator IBD Breakout Opportunities ETF (BOUT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


TMFXBOUTDifference

Sharpe ratio

Return per unit of total volatility

0.39

0.46

-0.07

Sortino ratio

Return per unit of downside risk

0.73

0.74

-0.01

Omega ratio

Gain probability vs. loss probability

1.10

1.10

0.00

Calmar ratio

Return relative to maximum drawdown

0.64

0.73

-0.09

Martin ratio

Return relative to average drawdown

2.23

2.03

+0.20

TMFX vs. BOUT - Sharpe Ratio Comparison

The current TMFX Sharpe Ratio is 0.39, which is comparable to the BOUT Sharpe Ratio of 0.46. The chart below compares the historical Sharpe Ratios of TMFX and BOUT, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


TMFXBOUTDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.39

0.46

-0.07

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.22

Sharpe Ratio (All Time)

Calculated using the full available price history

0.01

0.31

-0.30

Correlation

The correlation between TMFX and BOUT is 0.73, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.


Dividends

TMFX vs. BOUT - Dividend Comparison

TMFX's dividend yield for the trailing twelve months is around 0.05%, less than BOUT's 0.31% yield.


TTM20252024202320222021202020192018
TMFX
Motley Fool Next Index ETF
0.05%0.05%0.06%0.16%0.22%0.00%0.00%0.00%0.00%
BOUT
Innovator IBD Breakout Opportunities ETF
0.31%0.34%0.60%1.32%1.35%0.00%0.00%0.00%0.22%

Drawdowns

TMFX vs. BOUT - Drawdown Comparison

The maximum TMFX drawdown since its inception was -34.30%, smaller than the maximum BOUT drawdown of -36.75%. Use the drawdown chart below to compare losses from any high point for TMFX and BOUT.


Loading graphics...

Drawdown Indicators


TMFXBOUTDifference

Max Drawdown

Largest peak-to-trough decline

-34.30%

-36.75%

+2.45%

Max Drawdown (1Y)

Largest decline over 1 year

-14.74%

-13.73%

-1.01%

Max Drawdown (5Y)

Largest decline over 5 years

-28.28%

Current Drawdown

Current decline from peak

-11.01%

-5.33%

-5.68%

Average Drawdown

Average peak-to-trough decline

-14.74%

-12.55%

-2.19%

Ulcer Index

Depth and duration of drawdowns from previous peaks

4.25%

4.96%

-0.71%

Volatility

TMFX vs. BOUT - Volatility Comparison

The current volatility for Motley Fool Next Index ETF (TMFX) is 6.46%, while Innovator IBD Breakout Opportunities ETF (BOUT) has a volatility of 7.26%. This indicates that TMFX experiences smaller price fluctuations and is considered to be less risky than BOUT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


TMFXBOUTDifference

Volatility (1M)

Calculated over the trailing 1-month period

6.46%

7.26%

-0.80%

Volatility (6M)

Calculated over the trailing 6-month period

13.03%

17.22%

-4.19%

Volatility (1Y)

Calculated over the trailing 1-year period

23.11%

21.77%

+1.34%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

23.62%

19.54%

+4.08%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

23.62%

22.96%

+0.66%